SCHEMBL445994

SCHEMBL445994

CCC(O)Nc1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.45
CYP3A4 P08684 4/20 0.45
ALDH1A1 P00352 3/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
TSHR P16473 3/20 0.45
TP53 P04637 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HSP90AA1 P07900 1/20 0.45
THRB P10828 1/20 0.45
ALOX15 P16050 1/20 0.45
CASP1 P29466 1/20 0.45
HIF1A Q16665 1/20 0.45
HSD17B10 Q99714 1/20 0.45
RAB9A P51151 4/20 0.39
MAPT P10636 4/20 0.39
GAA P10253 1/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28024685 0.94 CYP3A4 (0.41) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL447463 0.81 CA12 (0.47) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL8907855 0.79 CA12 (0.46) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL31265919 0.79 ALDH1A1 (0.75) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL14532077 0.79 CYP3A4 (0.45) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL3241764 0.78 TDP1 (0.54) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL21799857 0.78 ALDH1A1 (0.48) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL347685 0.78 TDP1 (0.50) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL15609308 0.78 MAPT (0.38) TDP1CYP3A4ALDH1A1L3MBTL1TSHR
SCHEMBL249357 0.77 L3MBTL1 (0.78) TDP1CYP3A4ALDH1A1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4262692-A1 COMPOSITION COMPRISING THE COMBINATION OF AT LEAST ONE FATTY SUBSTANCE, A PARTICULAR CARBOXYLIC ACID AND AN OXIDATION DYE AND/OR AN ALKALINE AGENT L'OREAL (FR) 2023-10-25 EP claimed
WO-2022129384-A1 COMPOSITION COMPRISING THE COMBINATION OF AT LEAST ONE FATTY SUBSTANCE, A PARTICULAR CARBOXYLIC ACID AND AN OXIDATION DYE AND/OR AN ALKALINE AGENT L'OREAL (FR) 2022-06-23 WO claimed
EP-2658507-B1 OXIDATIVE COLOURING COMPOSITION KAO GERMANY GMBH (DE) 2019-04-24 EP claimed
US-8465552-B2 Thickened hair colors ISP INVESTMENTS, INC. (US) 2013-06-18 US claimed
US-20120317734-A1 THICKENED HAIR COLORS ISP INVESTMENTS INC. (US) 2012-12-20 US claimed
EP-1598049-B1 Composition for coloring of keratin fibres KPSS KAO GMBH (DE) 2008-08-06 EP claimed
EP-1250908-B1 Hair dye KPSS KAO GMBH (DE) 2007-03-14 EP claimed
US-6579326-B2 For dyeing hair L'OREAL S.A. (FR) 2003-06-17 US claimed
EP-1297818-A2 Hair dye KPSS-Kao Professional Salon Services GmbH (DE) 2003-04-02 EP claimed
US-6537328-B1 Hair dye L'OREAL S.A. (FR) 2003-03-25 US claimed
US-20030028975-A9 COMPOSITIONS FOR DYEING KERATIN FIBERS, CONTAINING CATIONIC INDOLIZINE DERIVATIVES, AND DYEING PROCESS L'OREAL S.A. (FR) 2003-02-13 US claimed
US-20020170122-A9 Compositions for the oxidation dyeing of keratinous fibers comprising at least one oxidation dye and at least one enzymatic oxidizing agent, and dyeing methods L'OREAL S.A. (FR) 2002-11-21 US claimed
EP-1250908-A2 Hair dye GOLDWELL GmbH (DE) 2002-10-23 EP claimed
US-20010044974-A1 Compositions for dyeing keratin fibers, containing cationic indolizine derivatives, and dyeing process BRETON PHILIPPE (FR) 2001-11-29 US claimed
US-20250319007-A1 15761 Fenway Avenue N. ELC MAN LLC (US) 2025-10-16 US disclosed
US-20250248914-A1 Hair Treatment Compositions With Amine Derivatives ELC MAN LLC (US) 2025-08-07 US disclosed
US-20250241835-A1 Hair Treatment Compositions With Amine Derivatives ELC MAN LLC (US) 2025-07-31 US disclosed
US-6238653-B1 ORGANIC, AMPHIPHILIC, SURFACE ACTIVE INGREDIENT CAPABLE OF INTERACTING WITH THE WATER PHASE AND THE OIL PHASE TO FORM LYOTROPIC LIQUID CRYSTALS CONTAINING SAID WATER PHASE INGREDIENTS REVLON CONSUMER PRODUCTS CORPORATION 2001-05-29 US disclosed
US-6143286-A USING A SILOXANE REVLON CONSUMER PRODUCTS CORPORATION (US) 2000-11-07 US disclosed
WO-2000007550-A1 METHOD FOR IMPROVING THE FADE RESISTANCE OF HAIR AND RELATED COMPOSITIONS REVLON CONSUMER PRODUCTS CORPORATION (US) 2000-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250241835-A1 Hair Treatment Compositions With Amine Derivatives ALKBH2, PNMT, ALDH7A1 TDP1 1193/4885CYP3A4 1586/4885ALDH1A1 52/4885
US-20010044974-A1 Compositions for dyeing keratin fibers, containing cationic indolizine derivatives, and dyeing process KRT18, INMT, KMO TDP1 2965/4885CYP3A4 1696/4885ALDH1A1 2691/4885
US-20250248914-A1 Hair Treatment Compositions With Amine Derivatives ALKBH2, ALDH7A1, ALKBH3 TDP1 1526/4885CYP3A4 1844/4885ALDH1A1 25/4885
US-20250319007-A1 15761 Fenway Avenue N. FEN1, OAT, ADH1A TDP1 1255/4885CYP3A4 565/4885ALDH1A1 15/4885
US-20020170122-A9 Compositions for the oxidation dyeing of keratinous fibers comprising at least one oxidation dye and at least one enzymatic oxidizing agent, and dyeing methods KRT18, PPOX, AOX1 TDP1 1275/4885CYP3A4 390/4885ALDH1A1 104/4885
US-20030028975-A9 COMPOSITIONS FOR DYEING KERATIN FIBERS, CONTAINING CATIONIC INDOLIZINE DERIVATIVES, AND DYEING PROCESS KRT18, INMT, KMO TDP1 3046/4885CYP3A4 1685/4885ALDH1A1 2493/4885
US-20120317734-A1 THICKENED HAIR COLORS KRT18, PLOD3, PLOD1 TDP1 3128/4885CYP3A4 1106/4885ALDH1A1 1954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.